Undisclosed oral hepcidin
/ Protagonist Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 06, 2025
Discovery and Development Pipeline
(ACCESS Newswire)
- "The Company plans to nominate a development candidate ready for IND-enabling studies from the oral hepcidin program by year end."
Pipeline update • Hematological Malignancies
1 to 1
Of
1
Go to page
1